PDSB
1.23 USD
+1.74%
Today
+2.63%
1D
Market is closed
Sun
Closed
Mon
Closed
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
PDS Biotechnology Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
66.98M
Avg Daily Volume
1.30M
52 Week High
1.915 USD
52 Week Low
0.507 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, Georgia Research Foundation, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
Top News
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
tradingview.com
1w ago
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
tradingview.com
2w ago
AmEagle
-0.24%
Allogene
+2.07%
Broadcom
+1.03%
BOAmerica
+0.80%
Allbirds
-5.96%
CSX.Corp
-0.92%
Precision.Bio
+0.99%
FirstHorizon
+0.58%
FNB_Corp
+0.34%
GitLab
+4.26%
RobinHood
-3.25%
IonQ.Inc
+8.10%
CarMax
+5.79%
EliLilly
+0.61%
MorganSt
+0.45%
NewmontM
+2.38%
NIKE
+0.69%
NatOilwell
-0.19%
NVIDIA
+0.85%
PDS.Biotech
+2.63%
PNCFin
+0.29%
Quantum.Computing
+4.77%
Rigetti.Computing
+0.83%
Revolution.Medicines
-1.34%
SnapInc
+0.88%
StoneCo
-0.90%
T1.Energy
-7.48%
Tempus.AI
-0.58%
UnionPacif
+0.41%
BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems
reuters.com
1mo ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
